Data / Research funding / New York / New York University D/b/a NYU Long Island School of Medicine
New York University D/b/a NYU Long Island School of Medicine: 13 NIH awards ($22.1M), fiscal years 2021 to 2026
New York University D/b/a NYU Long Island School of Medicine in Mineola, NY is funded under 13 NIH awards ($22.1M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- MKERJX2L6HG4
- State
- New York
Awards
13 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Biogenesis and Catabolism of Atherogenic Lipoproteins | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $7,418,574 | May 1, 2023 | April 30, 2028 | HUSSAIN, M MAHMOOD | reporter.nih.gov |
| Mapping MTP lipid transfer activities for better therapeutics | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,418,719 | April 1, 2021 | March 31, 2026 | HUSSAIN, M MAHMOOD | reporter.nih.gov |
| Role of NgBR in regulating hepatic gluconeogenesis and insulin resistance | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,299,513 | April 1, 2022 | March 31, 2027 | MIAO, QING | reporter.nih.gov |
| Regulation of plasma LDL and HDL by microRNA-541-3p | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,882,991 | June 1, 2023 | May 31, 2027 | HUSSAIN, M MAHMOOD | reporter.nih.gov |
| Role of Retinoid X Receptor Alpha in regulating PCSK9 transcription in the liver | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,789,027 | April 1, 2023 | January 31, 2027 | MIAO, QING | reporter.nih.gov |
| Placenta-specific miR-519c-mediated induction of immune tolerance in human placenta | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,440,259 | April 2, 2020 | March 31, 2025 | HANNA, NAZEEH N | reporter.nih.gov |
| Reducing Plasma Cholesterol and Atherosclerosis Using miR-30c Analog C2 | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,364,153 | September 24, 2025 | August 31, 2027 | HUSSAIN, M MAHMOOD | reporter.nih.gov |
| Bmal1, a master regulator of Macrophage cholesterol metabolism | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,102,308 | April 1, 2024 | March 31, 2028 | PAN, XIAOYUE | reporter.nih.gov |
| The long-term effectiveness of and the disparities in access to treatments for obstructive sleep apnea: a study on the All of Us data | NIH | National Institute on Minority Health and Health Disparities | 2022 | $843,332 | September 11, 2019 | February 28, 2025 | ZHANG, DONGLAN | reporter.nih.gov |
| Roles of Nogo-B receptor in maintaining the structural integrity of blood vessels | NIH | National Heart, Lung, and Blood Institute | 2021 | $511,814 | July 20, 2018 | June 30, 2024 | MIAO, QING | reporter.nih.gov |
| Role of NgBR in Hepatic Steatosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $408,222 | April 1, 2019 | March 31, 2023 | MIAO, QING | reporter.nih.gov |
| Circadian Regulation of Lipoprotein Assembly | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $346,500 | August 1, 2019 | April 30, 2023 | HUSSAIN, M MAHMOOD | reporter.nih.gov |
| Cold milk as a novel therapy for dysphagia in preterm infants | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $231,000 | August 28, 2020 | July 31, 2023 | HANNA, NAZEEH N | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 6 | $6,103,542 | 0 | $0 |
| 2024 | 7 | $5,838,688 | 0 | $0 |
| 2023 | 6 | $5,329,008 | 0 | $0 |
| 2022 | 4 | $2,359,120 | 0 | $0 |
| 2021 | 6 | $2,426,054 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Atherosclerosis
- Cardiovascular
- Digestive Diseases
- Prevention
- Liver Disease
- Genetics
- Biotechnology
- Clinical Research
- Nutrition
- Chronic Liver Disease and Cirrhosis
- Obesity
- Pediatric
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.